B+
Bull case
25%
Probability
Target price
$8.00
+6.1% vs current
TDOC
Teladoc HealthBNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$6.50
-13.8% vs current
B-
Bear case
25%
Probability
Target price
$4.50
-40.3% vs current
AI sentiment snapshot
Latest data as of 2026-05-05
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+33.1
Score
AI commentary
Near-term tone is cautious. The company delivered a cleaner quarter than feared on revenue and adjusted EBITDA versus its own guidance, but the immediate debate stayed focused on weak BetterHelp trends and negative free cash flow. Secondary coverage around the release reflected a mixed-to-negative market read, and the lack of robust analyst-revision breadth in the packet keeps conviction low rather than supportive of a sharp post-earnings rerating.
RankAlpha Sentiment Codex - 2026-05-05
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-03eventNext earnings checkpoint will test BetterHelp stabilization and segment margin follow-throughHigh impact
Management guided Q2 2026 revenue to $597-$626 million and adjusted EBITDA to $55-$67 million, with BetterHelp revenue expected down 11.75% to 5.25% year over year and BetterHelp margin between negative 0.5% and positive 1.5%. That makes the next quarterly update the clearest validation point for whether insurance-covered services and cost discipline can offset pressure in the consumer business [#8-K-2026-04-29].
2026-08-03catalystQ1 print beat the midpoint of company guidance but did not clear the BetterHelp overhangHigh impact
Q1 2026 revenue of $613.8 million and adjusted EBITDA of $58.2 million exceeded the midpoint of management's guidance, and the company reaffirmed the midpoint of its full-year outlook; however, BetterHelp revenue fell 9% year over year and BetterHelp adjusted EBITDA margin was only 0.9%, keeping the near-term debate centered on whether stabilization is real or temporary [#8-K-2026-04-29].
2027-05-05catalystIntegrated Care resilience and insurance-covered mental health expansion are the main turnaround leversHigh impact
Integrated Care revenue rose 2% year over year to $395.4 million, chronic care enrollment rose 4% to 1.197 million, and average monthly revenue per U.S. Integrated Care member increased to $1.30 even as U.S. Integrated Care members declined 1% to 101.2 million. Within BetterHelp, insurance-covered services contributed $12.9 million in Q1, but the broader segment still declined, so the long thesis remains a cautious execution story rather than a proven re-acceleration [#10-Q-2026-04-30].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-05 • Updated nightlySource: Internal modelMethodology